TGFB1 and cancer: The analysis revealed that ANOS1 is involved in the ECM receptor interaction, focal adhesion, hematological cell lineage, chemokine signaling pathway, pathways in cancer, and transforming growth factor (TGF)-β signaling pathway (Fig. 8).